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Abstract
The free radical hypothesis of aging proposes that deleterious actions of oxygen-derived radicals are responsible for the
functional deterioration associated with aging. Because cellular membranes house the production apparatus of these radicals
and because membranes suffer great damage from these radicals, modification of membrane lipids has been proposed to
play a major role in the process of aging. Although the relationships between lipid peroxidation and aging have been
investigated extensively, the studies have produced conflicting results. Increased lipid peroxidation and decreased
antioxidant protection frequently occur, but they are not universal features of aging. Instead, age-dependent changes in these
parameters appear to be species-, strain-, sex- and tissue specific. Potential correlations between lipid peroxidation and
transition metal concentrations or between lipid peroxidation and declining antioxidant protection have been obscured by the
contradictory nature of the findings. Future studies should focus on new approaches for the measurement in vivo lipid
peroxidation and on identification of the critical targets of lipid peroxidation. q 1997 Elsevier Science B.V.
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1. Introduction
In its original form, the free radical theory of aging
proposed that aging is due to the accumulation of
unrepaired damage from free radical attack on cellu-
w xlar components 1 . Modern thinking interprets the
free radical hypothesis in terms of oxidative stress,
and the reformulated theory proposes that aging is
caused by a shift in the balance between the pro-
oxidative and anti-oxidative processes in the direction
of the pro-oxidative state. It is postulated that aging
results from an increase in oxidative damage to lipids,
Abbreviations: TBARS, thiobarbituric acid reactive sub-
stances; MDA, malondialdehyde; GSH, reduced glutathione;
GSSG, glutathione disulfide; ESR, electron spin resonance
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proteins, or DNA or, alternatively, from the effect of
the oxidative stress on the regulation of genes that
govern developmental processes, including differenti-
w xation and aging 2–4 .
One of the fundamental assumptions of the free
radical theory is that the free radicals that contribute
to the aging process are derived directly or indirectly
from oxygen. As lipid peroxidation traditionally has
been regarded as the major process that produces
damage from oxygen radicals, the oxygen-based the-
ory is viewed by some as a lipid peroxidation theory
of aging. This idea is reinforced by the fact that
oxidized lipid residues are major components of lipo-
fuscin, the fluorescent pigment that accumulates with
w xage in most tissues 5,6 . Several offshoots of the
theory have been proposed to explain the link be-
tween peroxidation of membrane lipids and the func-
tional deterioration that characterizes the process of
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w xaging 7 . One of these hypotheses is that age-related
peroxidation of membrane lipids brings about fluidity
changes in the membranes, which in turn disrupt vital
functions, such as signal transduction or the mainte-
w xnance of selective permeability to ions 8–12 . An-
other hypothesis holds that age-associated patholo-
gies are related to increases in lysosomal enzyme
activities caused by destabilization of the lysosomal
w xmembrane 13 . Other ideas involve the production
and progressive accumulation of dysfunctional DNA
or protein molecules, arising from adduct formation
w xwith lipid peroxidation products 11,14–19 .
Although the relationships between lipid peroxida-
tion and the process of aging have been investigated
extensively, a number of issues remain unresolved.
This review article addresses the controversial find-
ings that have been obtained regarding age-associated
changes in lipid peroxidation and antioxidant status
and considers the extent to which lipid peroxidation
may contribute to the aging process. The chemistry of
lipid peroxidation, role of transition metals, and ef-
fects of antioxidants have been reviewed elsewhere in
w xdetail 20–22 . In addition, the relationships between
aging and oxidative damage to proteins or DNA are
beyond the scope of this review, and the reader is
directed to the excellent articles of other gerontolo-
w xgists for this information 3,16,23–26 .
2. Age-associated changes in lipid peroxidation
( )2.1. Thiobarbituric acid reacti˝e substances TBARS
A number of studies have examined the effect of
aging on various measures of lipid peroxidation in
tissues of mammalian origin. Most of these studies
have measured TBARS content as a marker of en-
dogenous lipid peroxidation, and the results have
been contradictory. Typical findings are shown in
Fig. 1, which contains results on TBARS from our
w xstudies with aging Fischer 344 rats 27 . The median
survival age for this strain of rats is 24 to 29 months,
and the ages studied represent young adulthood 4–5
.  .months , middle age 14–15 months , and old age
 .26–29 months . In our study, livers were removed
and quickly frozen in liquid nitrogen, homogenates
were prepared with buffer solution containing EDTA,
and the homogenates were immediately acidified with
 .thiobarbituric acid TBA reagent. The results show
that aging was associated with a 50% increase in
TBARS in livers of male rats, but the effect of aging
in female rats was a 50% decrease in hepatic TBARS.
Curiously, the age-dependent differences in TBARS
concentrations were not related to changes in antioxi-
dant molecules, as will be discussed below.
Results from studies of age-associated changes in
tissue levels of TBARS are summarized in Table 1.
Sex-dependent differences in the effects of aging are
evident for liver and brain of Wistar rats as well as
w xfor liver of Fischer 344 rats 11,27–32 . In addition,
age-associated changes that are seen in some organs
are not evident in others. The data for male Wistar
rats, for example, indicate that TBARS may increase
with age in liver and brain, but not in heart or lung
w x28,30,31 . Although fewer studies have used mice,
these studies also have produced conflicting results
w x33–36 . For example, hepatic TBARS concentrations
were elevated in old female C57BL mice but were
w xunaffected by aging in males 33,34 . These effects of
age and gender differ from those reported for rat
liver, where elevated TBARS are observed in old
males, but not in old females; likewise, the effect of
aging on TBARS in mouse kidney contrasts with that
reported for rat kidney i.e., unchanged in mice vs.
.  .decreased in rats Table 1 . Altogether, the findings
suggest that age-associated changes are species-,
strain-, sex-, and tissue-specific, and that increased
lipid peroxidation is not an inevitable consequence of
aging in any organ.
There are many uncertainties regarding conclu-
sions based on data obtained using the thiobarbituric
 .acid TBA assay. Many investigators report their
 .results as malondialdehyde MDA , although the as-
say is not specific for MDA. In most cases, investiga-
tors do not publish information about sample prepara-
tion or specific details about procedures for the assay.
These details are important to know, because artifacts
can arise from the exposure of tissues to oxygen. For
example, Massie et al. reported that storing samples
prior to analysis yielded TBA values that were higher
and more erratic than those obtained with fresh tissue
w xhomogenates 33 . Furthermore, the production of
TBA reactants during the period of reaction is af-
fected by metal ions, antioxidants and chelating
agents, as well as the type and concentration of acid
w xadded with the TBA 37 . These problems may have
contributed to the inconsistencies and contradictions
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 .Fig. 1. Effect of age and sex on contents of TBARS and antioxidant molecules in rat liver. TBARS MDA equivalents and antioxidant
w xconcentrations were measured in whole-cell homogenates prepared from livers of Fischer 344 rats, as described previously 27 . Values
 .  .  .  .are means of 6–7 rats aged 4–5 months Y , 14–15 months M , or 26–29 months O . Different letters a,b,c denote significant
 .differences between means of age groups within a given sex P-0.05, analysis of variance followed by Tukey’s test . The absence of
 .letters indicates there are no age-associated differences. Significant differences between sexes P-0.05 are designated by a a symbol
over the mean for male rats.
in the findings from aging studies. However, if the
medium used for tissue preparation contains a chelat-
 . ing agent e.g., EDTA and an antioxidant e.g.,
.butylated hydroxytoluene , and if conditions for the
assay are kept constant, then comparisons among age
groups within the same study should be valid, even
though absolute values for TBARS cannot be com-
pared from one study to the next.
2.2. Other indices of endogenous lipid peroxidation
Other investigators have studied the influence of
aging on lipid peroxidation using measures of en-
dogenous lipid peroxidation other than the TBARS
assay. Expiration of ethane and pentane is considered
to be one of the best indices of lipid peroxidation in
vivo, and three studies have measured exhaled alka-
w xnes in aging male rats 38–40 . Although the exhala-
tion of pentane increased markedly as a consequence
of aging, ethane exhalation increased only marginally
or not at all. Although the results for pentane suggest
that aging is accompanied by an increase in the rate
of lipid peroxidation; other factors also contribute to
the rate of alkane exhalation. Metabolism of alkanes
occurs in vivo and is more rapid for pentane than for
w xethane 41 . Moreover, the rate-limiting step in the
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Table 1
Tissue content of TBARS in aging rats and mice
Animal Organ
Species Strain Sex Liver Brain Heart Kidney Lung Ref.
a w xRat F344 M › y y y y 27
w xRat F344 F x y y y y 27
w xRat F344 F l l y y l 32
w xRat F344 M l y y y y 14
w xRat Wistar M › › l y y 28
w xRat Wistar F x x l x y 29
w xRat Wistar M l l y y l 30,31
w xMouse C57BL M l y y l y 33
w xMouse C57BL F › y y y y 34
w xMouse C3B10RF F l y y y y 351
w xMouse B6D2F NS y l y y y 361
aArrows indicate increased, decreased or unchanged TBARS
 .  .content in organs of old 24–32 months vs. mature 4–9 months
animals. NSsNot specified.
w xmetabolism is oxidation by cytochrome P450 41 ,
and it is well recognized that cytochrome P450-de-
pendent biotransformation decreases with age in male
w xrats 42–44 . Thus, the increase with age in pentane
exhalation could be a result of decreased pentane
clearance, rather than increased lipid peroxidation.
Other markers of endogenous lipid peroxidation
that have been studied as a function of aging include
tissue concentrations of lipid hydroperoxides or phos-
phatidylcholine hydroperoxides and lipid, protein or
DNA adducts of lipid peroxidation products i.e.,
.adducts of MDA or 4-hydroxy-2-nonenal
w x17,19,24,45–48 . The findings indicate that tissue
contents of hydroperoxides and aldehyde-adducts ei-
ther increase with age or remain unchanged, depend-
ing on the organ examined. For example, Miyazawa
w xet al. 47 found that phosphatidylcholine hydro-
peroxide concentrations increased in brain and liver
w xbut not lung of aging rats, and Draper et al. 19
found that deoxyguanosine-MDA adducts increased
with age in DNA from liver and kidney but not in
DNA from testes. Using a totally different approach,
Zhan and coworkers compared the electron spin reso-
 .nance ESR, or electron paramagnetic resonance
spectra produced by tissue plugs from liver and sex
w xglands of aging rats 39 . Tissue samples were frozen
in liquid nitrogen and cut into small rods, and the
frozen rods were placed directly into the lumen of an
ESR machine. ESR spectra were obtained that were
consistent with a lipid peroxyl radical and a
semiquinone radical; the signals were significantly
reduced in organs of old rats compared with those of
young-adult and middle-aged rats. Thus, inconsistent
findings regarding age-associated changes also have
been obtained with indices of lipid peroxidation other
than the measurement of TBARS.
Conflicting results from different studies may be
explained in part by species-, strain-, sex- and tissue-
specificity in the effects of aging, as mentioned above.
In addition, the discrepancies may relate, to an impor-
tant extent, to the use of undefined chow diets that
contain a variety of products, which may vary in
amount from batch to batch and from manufacturer to
manufacture and which often include fish products
with unknown amounts of oxidized lipids. Further-
more, most of the studies have not considered gross
and histopathological abnormalities that are common
in aged animals, nor have they been conducted using
pathogen-free animals. Thus, factors that contribute
to the state of oxidative stress in vivo also may have
confounded the results of studies on aging and lipid
peroxidation.
2.3. Magnitude and significance of age-associated
differences
A major unanswered question is the biological
importance of the magnitude of the reported age-re-
lated changes in endogenous lipid peroxidation. For
the most part, age-associated increases in various
indices of lipid peroxidation are in the range of 1.5 to
2-fold. Can this level of lipid peroxidation cause
enough membrane damage to produce detriments in
function? Toxicological studies in isolated hepato-
cytes and isolated perfused liver indicate that ex-
tremely high levels of intracellular reactive oxygen
are needed to cause acute cell injury, amounts that
are several orders of magnitude greater than can be
generated by intracellular processes under pathophys-
w xiological conditions 49 . However, the amount of
reactive oxygen needed to produce significant dam-
age in a chronic exposure situation in vivo is un-
known. Thus, there is a need to assess the conse-
quences of a two-fold increase in lipid peroxidation
over the lifetime of an animal. Such an assessment
would require the establishment of appropriate
physiological parameters for measurement, i.e., the
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identification of valid indices of pathological injury
andror biological markers of aging.
2.4. Lipid peroxidation potential
The findings considered thus are far from studies
aimed at investigating the effects of aging on endoge-
nous, or in vivo, lipid peroxidation. Also, there have
been investigations that employed in vitro lipid per-
oxidation systems and membranes isolated from ani-
mals of different ages to determine the effect of aging
w xon lipid per-oxidation potential 50–52 . The general
conclusions from recent studies are that lipid per-
oxidation potential is mainly a reflection of the de-
gree of unsaturation of the fatty acids present in the
membranes and that fatty acid unsaturation is a func-
w xtion of both diet and animal age 53,54 .
3. Age-associated changes in transition metal
concentrations
Transition metals promote lipid peroxidation in
 .two ways: 1 by catalyzing the formation of oxygen
free radical species capable of initiating lipid per-
 .oxidation and 2 by catalyzing the decomposition of
preformed lipid peroxides to propagate lipid per-
oxidation. The idea that elevated metal content of
tissues might be responsible for age-associated in-
creases in lipid peroxidation is not new. In fact, this
possibility was put forth more than a decade ago by
Massie and coworkers, who reported that total iron
concentrations in organs from male C57BL mice
w xwere elevated in old age 33 . Since then, evidence
has accumulated demonstrating age-associated in-
creases in transition metals, especially iron and cop-
w xper, in tissues of animals, including humans 55–61 .
It should be pointed out, however, that elevated metal
content is not a universal finding; like the changes in
lipid peroxidation and antioxidant protection, age-as-
sociated changes in metal content are tissue- and
sex-specific. As an example of the tissue specificity,
Sherman et al. reported that copper levels in male rats
increased with age in liver, kidney and spleen but not
w xin lung and heart 59 . Similarly, Persigehl et al.
found that trace element concentrations in human
organs depended on age and environmental influ-
ences but showed no clear correlation to either pa-
w xrameter 56 .
Nevertheless, several lines of evidence suggest that
iron ought to be involved in the lipid peroxidation
w xthat occurs with aging 62 . Age pigments contain
large amounts of iron, and there are reasons to be-
lieve that transition metal catalysis may be required
for pigment formation. For example, enhanced iron
levels in the medium of cultured rat cardiac myocytes
markedly increased lipofuscin accumulation, while
w xdeferoxamine had the opposite effect 63 . The ad-
ministration of iron to house flies also increased
lipofuscin accumulation and, at the same time, short-
w xened their life spans by one half 64 . Furthermore,
dietary tea, which inhibits the absorption of iron,
w xprolonged the life span of fruit flies 65 . In light of
the latter findings, it would seem important to deter-
mine if the life span of rodents could be extended by
lowering their tissue concentrations of iron by chronic
administration of an iron chelating agent, for exam-
ple.
There is some evidence also, based on serum
ferritin studies, that iron stores increase with age in
w xhumans as well as animals 66–71 . However, serum
ferritin concentrations may not be an accurate reflec-
tion of body iron stores, as conditions such as inflam-
mation, liver disease and increased red cell turnover
elevate serum ferritin concentrations to a dispropor-
tionate degree relative to body stores of iron. Mea-
surements of actual iron concentrations in human
organs have not demonstrated age-related increases in
all tissues. Notably, four studies measured hepatic
iron concentrations and found no age-dependent ele-
w xvation 55,56,70,71 , although a trend towards in-
creased iron stores was observed in women following
w xmenopause 70,71 . Interestingly, Halgren and
Sourander found that nonheme iron increased with
advancing age in almost every region of the human
brain, but iron concentrations in the brain were inde-
w xpendent of the amount of iron in the liver 55 . These
findings suggest that hepatic iron stores also are a
poor reflection of the iron content of other body
tissues. Additional information about the influence of
aging on iron stores in human organs is clearly
needed.
Most of the iron in vertebrate tissues is tightly
bound to proteins, and is not available for the promo-
tion of lipid peroxidation. Our studies in hepatocytes
of male rats indicated that approximately 5% of the
total nonheme iron in rat liver is present in the form
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Table 2
Low-molecular-weight-chelatable iron and total nonheme iron in
hepatocytes of mature and old rats
Age LMWC iron Total nonheme iron
2q .  .  .months nmol Fe rmg protein nmol Fermg protein
6 0.11"0.02 2.74"0.14
a a27 0.44"0.05 7.53"0.30
 .Low-molecular-weight-chelatable LMWC iron and total non-
heme iron were measured in freshly isolated hepatocytes of
mature and old male Fischer 344 rats, using ferene as the
w xchromogen 102 . Values are means " SE for six hepatocyte
preparations.
a  .Significantly different from mature rats P -0.05 .
 .of low-molecular-weight chelatable iron Table 2 .
Interestingly, we found that concentrations of low-
molecular-weight chelatable iron and of total non-
heme iron were 3 to 4 times higher in hepatocytes of
old rats than in those of mature rats, providing a
possible cause for an age-related increase in lipid
peroxidation. On the other hand, total nonheme iron
concentrations were still higher in livers of old fe-
 .male rats unpublished data , yet TBARS concentra-
tions were lower in old females than in old males.
The latter findings are consistent with a previous
study with mice in which elevations in total iron
concentrations were not accompanied by increases in
w xTBARS 33 . Thus, the importance of age-associated
elevations of iron stores to the lipid peroxidation that
is associated with aging remains controversial and
warrants further attention.
4. Age-associated changes in antioxidant
protection
4.1. Antioxidant enzyme acti˝ities
The influence of aging on antioxidant defenses has
been investigated extensively. Many studies have
shown that one or more of the antioxidant enzymes
or antioxidant molecules decrease as a consequence
of aging. This has led to the belief that aging is
associated with a decrease in antioxidant status and
that age-dependent increases in lipid peroxidation are
a consequence of diminished antioxidant protection.
A close examination of the published data, however,
indicate that age-related changes in antioxidant de-
fenses are quite varied.
The influence of aging on hepatic antioxidant en-
zyme activities of male and female Fischer 344 rats
w x  .are shown in Fig. 2 27 . Catalase, glutathione GSH
peroxidase, Cu, Zn-superoxide dismutase, and glu-
 .tathione disulfide GSSG reductase activities were
measured in post-mitochondrial supernatants pre-
pared from livers of rats whose ages ranged from
young adulthood to old age. Age-associated increases
in activity were as prevalent as decreases; and the
age-associated changes that were observed differed
between sexes. For example, catalase activity de-
creased with age in males and increased with age in
females.
Fig. 3 shows data from a parallel study, also in
Fischer rats, that demonstrate the effect of aging on
the mitochondrial activities of hepatic antioxidant
w xenzymes 72 . The changes found for mitochondrial
enzymes differ from those found for cytosolic en-
zymes. Significant differences between young-adult
and old rats were demonstrated for GSH peroxidase,
Mn-superoxide dismutase and GSSG reductase activi-
ties. These differences included age-related increases
as well as decreases and were different for males than
for females. We concluded that age-associated in-
creases in antioxidant enzyme activities counterbal-
anced the decreases, so that overall antioxidant pro-
tection was not significantly affected as a conse-
w xquence of aging 72 .
Our findings on antioxidant enzyme activities in
livers of aging Fischer rats are not unusual. Age-asso-
ciated changes in antioxidant protection appear to
depend on species, strain, sex and tissue studied. This
concept is illustrated by the data in Table 3, which
contains a selection of the reported findings on age-
dependent changes in GSH peroxidase activity. The
variation in results for GSH peroxidase activity in rat
heart, i.e., decreased, increased or unchanged in old
w xage 73–76 , is a good example of the inconsistency
in findings. Results for other antioxidant enzymes are
w xequally variable 27,29–32,72–83 .
We recently extended our studies of age-dependent
changes in antioxidant enzyme activities to include
several oxidoreductases that regulate the thiol-dis-
ulfide redox state. We found no age-dependent differ-
ences in thiotransferase, protein disulfide isomerase
or thioredoxin reductase activity in livers of male and
w xfemale Fischer 344 rats 84 . There was also no
change in the concentration of protein sulfhydryl
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 .  .Fig. 2. Effect of age and sex on antioxidant enzyme activities in rat liver cytosol. Catalase CAT , GSH peroxidase GPO , Cu,
 .  .Zn-superoxide dismutase SOD and GSSG reductase GRD activities were measured in post-mitochondrial supernatants of livers from
w xmale and female Fischer 344 rats 27 . Values are means " SE for six rats. Different letters denote significant differences between means
 .of age groups within a given sex P-0.05, analysis of variance followed by the Scheffe test . The absence of letters indicates there are
 .no age-associated differences. Significant differences between sexes P-0.05 are designated by a a symbol over the mean for male rats
 w x.Adapted from Rikans et al. 27 .
groups. Our previous studies had shown that liver
GSH concentrations are unaffected by aging, and that
GSSG reductase activity is either unchanged in
.  .males or increased in females as a consequence of
w xaging 27,85,86 . These findings demonstrate that the
capacity to maintain a reduced intracellular state can
be well preserved in old age.
4.2. Antioxidant molecules
Results from studies of the influence of aging on
the tissue contents of antioxidant molecules also have
led to contradictory conclusions regarding age-related
differences in antioxidant status and their contribu-
tion to the increased lipid peroxidation observed in
some tissues of old animals. The effect of aging on
tissue GSH content is particularly controversial, with
some investigators reporting substantial decreases in
old age and others reporting an absence of change
w x83 . Recent results for human subjects illustrate the
inconsistencies that typically are found. GSH concen-
trations in gastric mucosa decreased as a function of
age but not liver cirrhosis, whereas GSH levels in
plasma decreased with cirrhosis but not with aging
w x87 . Another problem is that the effects of aging on
tissue levels of lipid peroxidation products do not
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correlate well with changes in antioxidant molecules,
as illustrated by results from our studies in Fischer
 .rats Fig. 1 . We found that age-dependent differ-
ences in hepatic TBARS concentrations could not be
explained on the basis of the major biological anti-
oxidants, namely, vitamin E, GSH, and ascorbic acid.
One might point to the decrease in ascorbate to
account for the increase in TBARS in livers of old
male rats, but, in the light of the 2.5-fold increase in
vitamin E content, it would be difficult to argue that
antioxidant protection was diminished significantly in
these livers. Moreover, the TBARS content of female
rat liver decreased with age, yet concentrations of
biological antioxidants remained the same. An alter-
native explanation for our data is that the age-associ-
ated changes in biological antioxidants could have
been inconsequential because of an excess of antioxi-
 .dant protection in rat liver see below . In addition,
the increase in TBARS in male livers may have been
caused by an age-associated decrease in MDA
w xmetabolism 88,89 rather than an increase in lipid
peroxidation.
4.3. Magnitude and significance of age-related
changes in antioxidant status
The biological significance of the reported changes
in antioxidant molecules and antioxidant enzyme ac-
tivities can be questioned. The data in Fig. 1 are
fairly typical, in that age-associated decreases in ac-
tivity are in the order of 25 to 30%. Some of the
contradictions between findings from different groups
of investigators have occurred because decreases that
are not statistically significant in one study are slightly
more substantial in another study of same model; the
former are reported as maintenance of protection,
while the latter are extolled as evidence of a signifi-
cant decline in antioxidant defense. Moreover, there
may be an excess of antioxidant protection in many
w xtissues 3 . For example, studies in isolated hepato-
cytes indicated that catalase activity could be inhib-
ited more than 70% without affecting sensitivity to
w xdiquat-induced cell killing 89 . Likewise, studies
Fig. 3. Effect of age and sex on antioxidant enzyme activities in
 .rat liver mitochondria. GSH peroxidase GPO , Mn-superoxide
 .  .dismutase SOD , and GSSG reductase GRD activities were
measured in liver mitochondria of male and female Fischer 344
w x  .rats 72 . Different letters a,b denote significant differences
between means of age groups within a given sex P -0.05,
.analysis of variance followed by Tukey’s test . The absence of
letters indicates there are no age-associated differences. Signifi-
 .cant differences between sexes P -0.05 are designated by a a
symbol over the mean for male rats Adapted from Rikans et al.
w x.72 .
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Table 3
GSH peroxidase activity in organs of aging rats and mice
Animal Organ
Species Strain Sex Liver Brain Heart Kidney Muscle Lung Ref.
a w xRat F344 M l y y y y y 27
w xRat F344 M x l x x y y 76
w xRat F344 F x Cerebrum l y y y l 32
w xRat F344 F l y y y y y 27
w xRat Wistar M l l y y y l 30,31
w xRat Wistar M x x x x x x 39
w xRat Wistar M y y y y y › 77
w xRat Wistar M › y y y y y 78
w xRat Wistar M x y l y y y 75
w xRat Wistar M y Caudate putamen › y y y y 79
bPar.temp.cortex ›
Substantia nigra l
Thalamus x
w xRat Wistar F x l l x y y 29
w xRat Wistar F y y y y y x 77
w xRat Wistar-Furth M l y y y › y 80
w xRat Sprague-Dawley M y y › y › y 74
w xMouse C57BL M x y l x y y 81
w xMouse C57BL M y › l x y y 82
w xMouse C57BL F x y y y y y 35
a  .  .Arrows indicate unchanged, decreased or increased activity in organs from old 23–30 months vs. mature 3–10 months animals.
b Parieto-temporal cortex.
with Drosophila melanogaster mutants demonstrated
that only 50% of the normal Cu, Zn-superoxide
dismutase activity and 5–14% of the normal catalase
activity were sufficient to withstand experimentally
induced oxidative stress and to achieve a normal life
w xspan 90,91 . Thus, it is difficult to know if decreases
of 25 to 30% in antioxidant enzyme activities jeopar-
dize the antioxidant status of the cell or have any
relevance to the aging process.
5. Causality of lipid peroxidation in the aging
process
One of the problems faced by gerontologists is that
of separating events that cause aging from those that
are caused by aging processes. The evidence regard-
ing lipid peroxidation is a clear example of this
dilemma. In support of a causal role for lipid per-
oxidation is the substantial body of evidence that
shows a positive correlation between concentrations
of lipid peroxidation products and animal age. Fur-
thermore, caloric restriction, the only treatment known
to retard the process of aging and extend the life span
of animals, inhibits the age-associated increase in
lipid peroxidation and prevents the decline in antioxi-
w xdant protection 10,34,39,45,53,76,83,92 . The obvi-
ous caveat is that age-associated changes in a number
of factors are reversed by caloric restriction and it
remains to be shown that any of these factors is a
direct cause of aging.
Conversely, the elevations in products of lipid
peroxidation that have been observed in aging tissues
may be caused by age-related alterations in processes
other than lipid peroxidation. In this regard, there is
good evidence that aging is associated with a de-
crease in the metabolism of certain products of lipid
peroxidation. For example, age-associated diminu-
tions have been reported for metabolism of MDA and
4-hydroxy-2-nonenal by liver fractions and isolated
w xhepatocytes 48,88,89 . Although an effect of aging
on the biotransformation of ethane and pentane has
not been reported, it seems likely that metabolism of
these hydrocarbons, may also decrease in old age,
especially in male rats where several cytochrome
P450-dependent biotransformation reactions are
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wmarkedly diminished as a consequence of aging 42–
x44 .
6. Conclusions
Although there are numerous reports of age-associ-
ated elevations in lipid peroxidation, reports of de-
creased or unchanged lipid peroxidation have also
been frequent. The same applies to age-associated
decreases in antioxidant defenses. The effects of ag-
ing appear to be species-, strain-, gender- and tissue
specific, yet there is no particular pattern that ex-
plains why lipid peroxidation is increased with age in
 .some cases tissues, strains, etc. and not in others. It
is clear that additional correlative data will not pro-
vide new insight into the role of lipid peroxidation in
the aging process.
Quantitative considerations are frequently over-
looked aspects of free radical injury in vivo, and this
aspect of oxygen-induced damage needs to be ad-
dressed in the context of aging. At present there is
very little information about the consequences of
chronic exposure to pathophysiological levels of ox-
idative stress in vivo. It is possible that the magnitude
of the changes that occur in some tissues as a conse-
quence of aging may not be detrimental to normal
function.
Evidence to prove or disprove a lipid peroxidation
theory of aging awaits the development of new ap-
proaches to test the hypothesis. One approach would
be to develop ways of manipulating rates of lipid
peroxidation in vivo by magnitudes that are physio-
logically relevant and then determine whether or not
these manipulations affect the life spans of mammals.
This would also require the development of improved
methods for the measurement of lipid peroxidation in
vivo. Past investigations have relied mostly on the
measurement of lipid peroxidation products; the prob-
lem with that approach is that age-dependent effects
on the processes responsible for the removal or repair
of these products have not been considered. Measure-
ment of ethane and pentane exhalation is the best
method available at present for the estimation of lipid
peroxidation in vivo. Yet several factors besides the
rate of lipid peroxidation contribute to the rate of
alkane exhalation, including dietary macronutrients,
oxygen concentration at the site of production, and
alkane biotransformation; and compensation for age-
dependent changes in these influences is rarely made.
New advances are also needed in the identification of
 .the critical target s of lipid peroxidation. The formu-
lation of testable hypotheses regarding the causality
of lipid peroxidation depends on the development of
specific ideas regarding sites and consequence of the
peroxidative damage to membrane lipids.
Many theories have been proposed regarding the
basic nature of aging, but none has been validated as
an explanation for intrinsic biological aging. Most
gerontologists take the view that theories of aging are
not mutually exclusive and that aging is a multicausal
phenomenon. It seems likely, therefore, that lipid
peroxidation could be one of several factors that
contribute to the process of aging, but the contradic-
tory nature of the findings to date suggest that lipid
peroxidation is not a major cause of aging.
7. Future perspectives
The free radical hypothesis of aging is very attrac-
tive because it provides an explanation for biological
aging that can be investigated at the molecular level.
The basic tenet of the hypothesis is that age-related
loss of function is due to the progressive and irre-
versible accrual of molecular oxidative damage to
w xessential macromolecules 1,26,93 . The fact that re-
active oxygen species are produced continuously and
at a high rate as by-products of aerobic metabolism
suggests that the mitochondrion is the critical site of
the oxidative damage, and data are accumulating to
suggest that molecules other than membrane phos-
w xpholipids are the critical targets 12,24,82,94 . Some
evidence indicates that the accrual of oxidatively
damaged DNA may be a major cause of the physio-
logical changes associated with the aging process
w x24,95–97 . For example, steady-state levels of 8-
oxoguanine, a product of hydroxyl radical- and sin-
glet oxygen-mediated DNA damage, increase with
age in a variety of tissues and could be responsible
for age-related increases in somatic mutations or
w xmitochondrial DNA deletions 95,97 . There is also
evidence to suggest that oxidation of proteins may be
w xa major cause of aging 14–16,82,94,98,99 . For
example, studies with ad libitum fed and caloric
restricted mice demonstrated that protein oxidative
( )L.E. Rikans, K.R. HornbrookrBiochimica et Biophysica Acta 1362 1997 116–127126
damage is associated with aging, and that dietary
restriction, which prolongs life span, lessens this
w xdamage 82 . Another way that oxidative stress may
contribute to cellular aging is by affecting gene ex-
w xpression 3,4,100,101 . In this respect, aging-induced
up-regulation of the nuclear binding activities of NF-
kB, a transcription factor that responds to oxidative
stress, was recently demonstrated in mouse cardiac
w xmuscle 101 . The free radical hypothesis of aging
provides a framework for many interesting avenues
of investigation and it is clear that additional research
is needed to complete our understanding of the role
of oxidative stress in the aging process.
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